BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lim JH, Lee DH, Lee ST, Kim N, Park YS, Shin CM, Song IS. Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori infection. World J Gastroenterol 2015; 21(46): 13124-13131 [PMID: 26673999 DOI: 10.3748/wjg.v21.i46.13124]
URL: https://www.wjgnet.com/1007-9327/full/v21/i46/13124.htm
Number Citing Articles
1
Dan Wang, Qianqian Guo, Yuan Yuan, Yuehua Gong. The antibiotic resistance of Helicobacter pylori to five antibiotics and influencing factors in an area of China with a high risk of gastric cancerBMC Microbiology 2019; 19(1) doi: 10.1186/s12866-019-1517-4
2
Hideki Mori, Hidekazu Suzuki. Update on quinolone-containing rescue therapies for <i>Helicobacter pylori</i> infectionWorld Journal of Gastroenterology 2020; 26(15): 1733-1744 doi: 10.3748/wjg.v26.i15.1733
3
Muhammet Yener Akpinar, Evrim Kahramanoglu Aksoy, Ferdane Sapmaz, Zeynep Goktas, Metin Uzman, Yasar Nazligul. Comparison of moxifloxacin-based therapies and standard bismuth-based quadruple therapy for first-line treatment of Helicobacter pylori infectionArchives of Medical Science – Civilization Diseases 2018; 3(1): 81 doi: 10.5114/amscd.2018.78766
4
Sumaira Khadim, Iyad Naeem Muhammad, Tanveer Alam, Shahnaz Usman, Hina Rehman, Sajjad Haider. Predictors of Successful First-Line Helicobacter pylori Eradication with Fluoroquinolones in Pakistan: A Prospective Exploration of Demographic and Clinical FactorsAntibiotics 2024; 13(3): 211 doi: 10.3390/antibiotics13030211
5
Taraneh Mousavi, Shekoufeh Nikfar, Mohammad Abdollahi. The pharmacotherapeutic management of duodenal and gastric ulcersExpert Opinion on Pharmacotherapy 2022; 23(1): 63 doi: 10.1080/14656566.2021.1959914
6
Alicia C. Marin, Olga P. Nyssen, Adrian G. McNicholl, Javier P. Gisbert. Efficacy and Safety of Quinolone-Containing Rescue Therapies After the Failure of Non-Bismuth Quadruple Treatments for Helicobacter pylori Eradication: Systematic Review and Meta-AnalysisDrugs 2017; 77(7): 765 doi: 10.1007/s40265-017-0730-4
7
Brian White, Maria Winte, Joshua DeSipio, Sangita Phadtare. Clinical Factors Implicated in Antibiotic Resistance in Helicobacter pylori PatientsMicroorganisms 2022; 10(2): 322 doi: 10.3390/microorganisms10020322
8
Anthony O'Connor, Wolfgang Fischbach, Javier P. Gisbert, Colm O'Morain. Treatment of Helicobacter pylori infection 2016Helicobacter 2016; 21(S1): 55 doi: 10.1111/hel.12342
9
Andrzej Czyrski, Agnieszka Sokół, Edyta Szałek. HPLC method for determination of moxifloxacin in plasma and its application in pharmacokinetic analysisJournal of Liquid Chromatography & Related Technologies 2017; 40(1): 8 doi: 10.1080/10826076.2017.1280680
10
Darsh Gautam, Poonam Talwan, Sahil Dhiman, Rahul Gill, Aparna Thakur, Simran Dhiman, Deexa Sharma, Akhil Kumar, Saksham Sharma. Amoxicillin-loaded Nanotechnological Carriers for the Effective Treatment of Helicobacter pylori InfectionMicro and Nanosystems 2023; 15(4): 245 doi: 10.2174/0118764029259927231127094657
11
Yuehua Gong, Yuan Yuan. Resistance mechanisms ofHelicobacter pyloriand its dual target precise therapyCritical Reviews in Microbiology 2018; 44(3): 371 doi: 10.1080/1040841X.2017.1418285
12
Jing Yu, Yiming Lv, Peng Yang, Yizhou Jiang, Xiangrong Qin, Xiaoyong Wang. Alcohol increases treatment failure for Helicobacter pylori eradication in Asian populationsBMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-03002-z
13
Emily C. Tucker, Matthew B. Roberts, David L. Gordon. A Worldwide Yearly Survey of New Data in Adverse Drug ReactionsSide Effects of Drugs Annual 2017; 39: 229 doi: 10.1016/bs.seda.2017.07.005